1024 related articles for article (PubMed ID: 29878845)
21. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
[TBL] [Abstract][Full Text] [Related]
22. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
Argentou M; Tiniakos DG; Karanikolas M; Melachrinou M; Makri MG; Kittas C; Kalfarentzos F
Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
24. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
[TBL] [Abstract][Full Text] [Related]
25. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
26. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
[TBL] [Abstract][Full Text] [Related]
27. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
28. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
29. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
Kashyap SR; Diab DL; Baker AR; Yerian L; Bajaj H; Gray-McGuire C; Schauer PR; Gupta M; Feldstein AE; Hazen SL; Stein CM
Obesity (Silver Spring); 2009 Sep; 17(9):1696-701. PubMed ID: 19360015
[TBL] [Abstract][Full Text] [Related]
30. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
[TBL] [Abstract][Full Text] [Related]
31. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
Pacifico L; Bezzi M; Lombardo CV; Romaggioli S; Ferraro F; Bascetta S; Chiesa C
World J Gastroenterol; 2013 Jul; 19(25):4007-14. PubMed ID: 23840146
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
Jamali R; Arj A; Razavizade M; Aarabi MH
Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
[TBL] [Abstract][Full Text] [Related]
33. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
[TBL] [Abstract][Full Text] [Related]
34. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
35. GDF11 induces mild hepatic fibrosis independent of metabolic health.
Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
[TBL] [Abstract][Full Text] [Related]
36. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
[TBL] [Abstract][Full Text] [Related]
37. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
Clemente MG; Mandato C; Poeta M; Vajro P
World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
[TBL] [Abstract][Full Text] [Related]
38. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease.
Abenavoli L; Luigiano C; Guzzi PH; Milic N; Morace C; Stelitano L; Consolo P; Miraglia S; Fagoonee S; Virgilio C; Luzza F; De Lorenzo A; Pellicano R
Panminerva Med; 2014 Jun; 56(2):189-93. PubMed ID: 24994581
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]